Research In Brief
This article was originally published in The Gray Sheet
Hospital re-admission as quality marker?
You may also be interested in...
CMS on Aug. 1 formally adopted two policies from the health care reform law that will have significant implications for its long-term approach to value-based reimbursement.
Lannett will launch a further seven products in fiscal 2021, after launching four products recently in the first quarter of FY21. The company also plans to pay off its Term Loan ‘A’ in full, by the end of November 2020.
Pfizer has now received a formal European Commission approval for its Nyvepria biosimilar pegfilgrastim. The approval puts the firm in direct competition with several other versions of the Neulasta original.